Our Values

We will carefully select, train and develop our people to be creative and empower them to take decisions…

Our Mission

Patient Care
Cost Effectiveness

Our Vision

To acquire and maintain global leadership position in chosen areas of businesses.


About Lebiran

Lebiran was founded in 2014. It is an import, export and trade company of bio-similar products in the field of immunological treatments, infertility, hormone disorders and oncology. The main goal of Lebiran is to have hi-tech products in order to support patients with rare diseases with their suitable, best quality, and best prices treatments.

Lebiran is a newly started company, and the aim is to let it grow to be one of the biggest companies. The concept is to be active in the research to know the market need for specific products and then to work on having the needed products to cover the entire market.

Our Featured Products


Description Zytux™ is a biosimilar product with the generic name of Rituximab. It is a genetically engineered human-mouse chimeric monoclonal antibody produced by Chinese Hamster Ovary (CHO) [...]


Description Stivant™ is a biosimilar product with generic name of Bevacizumab. Stivant is a recombinant monoclonal antibody that belongs to antiangiogenic group of medicines. It binds to cell [...]


Description AryoTrust™ is a biosimilar product with the generic name of Trastuzumab. AryoTrust™ is a recombinant DNA-derived humanized monoclonal antibody that selectively targets the [...]


Description Altebrel™ is a biosimilar product with the generic name of Etanercept. Etanercept is a fusion protein consisting of FC part of antibodies and two TNF receptors. Indication Etanercept [...]


Description LENALIDOMIDE a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and antineoplastic properties. Indication LENALIDOMIDE in combination with dexamethasone is [...]


  Description ALVOCADE® for Injection contains Bortezomib which is an antineoplastic agent. BORTEZOMIB is a modified dipeptidyl boronic acid.   Indication Bortezomib is indicated for [...]


(Adalimumab) Beyond the symptom control Description CinnoRA® (Adalimumab) is a recombinant monoclonal antibody that binds to human tumor necrosis factor alpha (TNF-alpha), thereby interfering [...]

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search